UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 9, 2019

 

 

Pfenex Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36540   27-1356759

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

10790 Roselle Street

San Diego, CA 92121

(Address of principal executive offices, including zip code)

(858) 352-4400

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.001 per share   PFNX   NYSE American

 

 

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

As noted below, on May 9, 2019, our stockholders approved the amendment and restatement of our 2014 Equity Incentive Plan (1) to increase the number of shares of common stock reserved thereunder by 2,000,000 shares; and (2) to make such other changes as described in the proxy statement. The Amended and Restated 2014 Equity Incentive Plan is described in more detail in the Company’s 2019 Proxy Statement, which was filed with the Securities and Exchange Commission on April 4, 2019. The foregoing description and the summary contained in the Company’s 2019 Proxy Statement do not purport to be complete and are qualified in their entirety by reference to the full text of the Amended and Restated 2014 Equity Incentive Plan, which is attached hereto as Exhibit 10.1.

Item 5.07 Submission of Matters to a Vote of Security Holders.

We held our 2019 annual meeting of stockholders on May 9, 2019 (the “Annual Meeting”). Of the 31,485,199 shares of our common stock outstanding as the record date of March 14, 2019, 29,934,557 shares were represented at the Annual Meeting, either in person or by proxy, constituting approximately 95% of the outstanding shares of common stock. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below:

 

1.

Election of Class  II Directors.  Each of the following nominees was elected to serve as a Class II director, to hold office until our 2022 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified or his or her earlier resignation or removal based on the following results of voting:

 

Nominee

   Votes For      Votes Withheld      Broker Non-
Votes
 

Phillip M. Schneider

     19,090,048        4,417,741        6,426,768  

Robin D. Campbell, Ph.D.

     18,740,261        4,767,528        6,426,768  

Magda Marquet, Ph.D.

     22,805,824        701,965        6,426,768  

 

2.

Approval of Amended and Restated 2014 Equity Incentive Plan.  The amendment and restatement of the Company’s 2014 Equity Incentive Plan was approved, including (1) an increase in the number of shares of common stock reserved thereunder by 2,000,000 shares; and (2) such other changes as described in the Proxy Statement.

 

Votes For

   Votes Against    Abstentions    Broker Non-
Votes
17,942,816    5,443,776    121,197    6,426,768

 

3.

Ratification of Appointment of Independent Registered Public Accounting Firm.  The appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019 was ratified based on the following results of voting:

 

Votes For

   Votes Against    Abstentions    Broker Non-
Votes
29,766,270    57,576    110,711   

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.

  

Description

10.1    Amended and Restated 2014 Equity Incentive Plan and forms of award thereunder.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    PFENEX INC.

Date: May 9, 2019

    By:   /s/ Susan A. Knudson
      Susan A. Knudson
     

Chief Financial Officer

(Principal Financial Officer)

Pfenex (AMEX:PFNX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Pfenex Charts.
Pfenex (AMEX:PFNX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Pfenex Charts.